Global Business Footprints
Home  Global Business Footprints
Facilitated good volume of product registrations in
- Latin America – Mexico, Brazil, Venezuela, DR, Peru, Bolivia, Uruguay & Caribbean Island
- African subcontinent
- MENA region
- South East Asia
- CIS - Russia, Ukraine
Mediated several outlicensing projects in Europe, Latin America, South East Asia.
Established widespread pharma distributor and partner network in –
Lat Am –
Brazil, Chile, Mexico, Argentina, Columbia
Tier 2 : T&T, Equador, Uruguay, Paraguay, Guatemala, Venezuela, DR
Tier 3 : Honduras, Bolivia, Entire Caribbean, Panama, Suriname.
Africa : All the Francophonic Africa countries, RSA, East, West Africa & Central Africa.
Middle East : GCC & non GCC countries including Iran
Rest of Asia & Australia, NZ
Europe : France, Germany, Spain, Portugal, Italy, Eastern Europe & the Baltics
- Initiated pharma product commercialization in many countries of Lat Am, Africa, MENA, SE Asia, CIS.
- Good number of API supply deals for the Latin American regions, the MENA and Europe.
- Several site variation & API variation projects for European manufacturing plants.
- Technology transfer platforms & turnkey projects in the area of biosimilar development especially for recombinant therapeutics for clients from the GCC & Lat Am.
- Set up loan licensing partners for product manufacturing for several Indian clients.
|
|
|
